Home > PB Ratio > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of SUVEN PHARMACEUTICALS is 14.04.

Share Price ₹1,130.1Feb 05,2025
Market Cap ₹28,771.1 Cr
Book Value₹2,048.7 CrMar2024 - Consolidated Results
Price/Book 14.04xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of SUVEN PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of SUVEN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹28,771.1 Cr] as on Feb 05,2025

(/) Book Value [ ₹2,048.7 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 14.04x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '14.04 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SUVEN PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of SUVEN PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of SUVEN PHARMACEUTICALS


PB Ratio Performance Analysis for SUVEN PHARMACEUTICALS

- SUVEN PHARMACEUTICALS 's latest p/b ratio is 14.04x.

- SUVEN PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.87x.

- SUVEN PHARMACEUTICALS 's operated at median p/b ratio of 8.41x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 10.68x.

- SUVEN PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 3.04x.


How does SUVEN PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
SUVEN PHARMACEUTICALS 2,048.6714.0428,771.1
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.61420,699.0
CIPLA LTD26,619.904.36116,022.0
DR REDDYS LABORATORIES LTD28,123.503.64102,463.0
ZYDUS LIFESCIENCES LTD19,829.504.9698,434.8
DIVIS LABORATORIES LTD13,571.0011.98162,584.0
MANKIND PHARMA LTD9,339.8410.97102,447.0
TORRENT PHARMACEUTICALS LTD6,856.1515.38105,449.0
LUPIN LTD14,175.807.0499,816.4
AUROBINDO PHARMA LTD29,842.802.3269,222.8
ABBOTT INDIA LTD3,658.7316.1459,040.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SUVEN PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.32x
Max industry PB 16.14x
Median industry PB 7.04x
Average industry PB 8.86x



You may also like the below Video Courses